AccutarBio Company
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Founded Date:
2015-01-01
Total Funding:
76613745.0
Investor Type:
For Profit
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
Artificial Intelligence, Biopharma, Biotechnology, Machine Learning
Last Funding Type:
Venture - Series Unknown
Investors Number:
3.0
Last Funding Date:
2021-01-05
Industry:
Early Drug Development
Headquarters:
Shanghai, Shanghai, China
Estimated Revenue:
Less than $1M